Toronto Sun · Toronto Star
Jim Keon
Last published July 2023 · On our record since 2011
Where this writer stands
No opinion piece by this writer has been scored on a policy topic yet.
Only opinion columns and editorials are scored. Each piece is read twice by a language model, which records the author's own stance on a policy topic only where the piece argues one, with a quote that must appear in the piece. An author's position on a topic is the average of their pieces, weighted by the model's confidence. News reporting is listed but never scored.
Recent work
- KEON: Feds should address shortages and cost pressures in Canadian medicationsOpinion · Toronto Sun · Jul 4, 2023
- KEON: Biosimilars switching policy would save Ontario millionsOpinion · Toronto Sun · Nov 4, 2022
- Opinion | Protecting domestic generic drug manufacturing is vital to national pharmacare planOpinion · Toronto Star · Apr 14, 2022
- Opinion | Increasing the use of generic drugs is one anti-inflation tacticOpinion · Toronto Star · Oct 26, 2021
- EU’s stand on drug patents will be costly for OntarioOpinion · Toronto Star · Sep 29, 2011
- EU’s stand on drug patents will be costly for Ontario | The StarOpinion · Toronto Star · Sep 28, 2011